Amalia Hadjimichael is 10% at Karyopharm Therapeutics Inc. (KPTI). They have made 5 open-market trades across 1 company since 2014, most recently 2014-12-01.
CIK 0001591257
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KPTI | 9,132,700 | $3.5M |
Shares reported on the most recent Form 4, priced at the 2014-12-01 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 0% | 0% |
| Avg Move | -46.9% | +3.0% | +3.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KPTI | SELL | 2014-11-26 | 2014-12-01 | $41.92 | $11.7M | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-09-12 | 2014-09-16 | $41.12 | $177K | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-08-25 | 2014-08-27 | $38.08 | $167K | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-08-18 | 2014-08-21 | $39.10 | $124K | -46.9% | +3.0% | +3.0% |
| KPTI | SELL | 2014-07-29 | 2014-07-31 | $35.20 | $1.1M | -46.9% | +3.0% | +3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.